Published in Transplantation on November 15, 2011
Mixed chimerism and split tolerance: mechanisms and clinical correlations. Chimerism (2012) 0.83
CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood (2007) 2.68
BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. J Leukoc Biol (2009) 1.53
Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Diabetes (2006) 1.05
Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival. Am J Transplant (2004) 1.00
Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation. Transpl Int (2008) 1.00
Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras. J Immunol (2008) 0.95
The ability of natural tolerance to be applied to allogeneic tissue: determinants and limits. Biol Direct (2007) 0.95
Thymic cortical epithelium induces self tolerance. Eur J Immunol (2005) 0.95
Decellularization reduces the immune response to aortic valve allografts in the rat. J Thorac Cardiovasc Surg (2005) 0.95
Coinhibitory T-cell signaling in islet allograft rejection and tolerance. Cell Transplant (2006) 0.92
Non-myeloablative mixed chimerism approaches and tolerance, a split decision. Eur J Immunol (2007) 0.88
Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning. Transplantation (2005) 0.86
A nude mouse model of hypertrophic scar shows morphologic and histologic characteristics of human hypertrophic scar. Wound Repair Regen (2012) 0.84
Mixed chimerism and split tolerance: mechanisms and clinical correlations. Chimerism (2012) 0.83
Differential susceptibility of allogeneic targets to indirect CD4 immunity generates split tolerance. J Immunol (2008) 0.83
The role of co-inhibitory signals in spontaneous tolerance of weakly mismatched transplants. Immunobiology (2011) 0.82
Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival. Transplantation (2007) 0.81
Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction. Cell Transplant (2006) 0.80
Compaction of islets is detrimental to transplant outcome in mice. Transplantation (2006) 0.80
Mechanisms and models of peripheral CD4 T cell self-tolerance. Front Biosci (2004) 0.80
Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats. Transplantation (2009) 0.79
Control of in vivo collateral damage generated by T cell immunity. J Immunol (2013) 0.78
Co-inhibitory molecules: Controlling the effectors or controlling the controllers? Self Nonself (2010) 0.78
Povidone-Iodine Irrigation of Subcutaneous Tissues May Decrease Surgical Site Infections in Elective Colorectal Operations: A Systematic Review. Gastroenterology Res (2011) 0.77
PD-1 is not required for natural or peripherally induced regulatory T cells: Severe autoimmunity despite normal production of regulatory T cells. Eur J Immunol (2014) 0.77
Soluble donor DNA and islet injury after transplantation. Transplantation (2011) 0.76
A discussion of immune tolerance and the layered immune system hypothesis. Chimerism (2013) 0.75
Comment on: Ten experiments that would make a difference in understanding immune mechanisms. Cell Mol Life Sci (2011) 0.75
Toward minimal conditioning protocols for allogeneic chimerism in tolerance resistant recipients. Chimerism (2013) 0.75
Divide and conquer: Blocking graft versus host but not graft versus leukemia T cells with agonist BTLA co-inhibitory signals. Chimerism (2011) 0.75
Morphologic and Histologic Comparison of Hypertrophic Scar in Nude Mice, T-Cell Receptor, and Recombination Activating Gene Knockout Mice. Plast Reconstr Surg (2015) 0.75
An essential role for programmed death-1 in the control of autoimmunity: implications for the future of hematopoietic stem cell transplantation. Future Oncol (2011) 0.75
T cells generated in the absence of a thoracic thymus fail to establish homeostasis. Eur J Immunol (2014) 0.75